Implantica AG (STU:8IM1) Short-Term Capital Lease Obligation : €0.00 Mil (As of . 20)

View and export this data going back to 2020. Start your Free Trial

What is Implantica AG Short-Term Capital Lease Obligation?

Implantica AG's Short-Term Capital Lease Obligation for the quarter that ended in . 20 was €0.00 Mil.

Implantica AG Short-Term Capital Lease Obligation Historical Data

The historical data trend for Implantica AG's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Implantica AG Short-Term Capital Lease Obligation Chart

Implantica AG Annual Data

Trend

Short-Term Capital Lease Obligation

Implantica AG Semi-Annual Data

Short-Term Capital Lease Obligation

Implantica AG Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Implantica AG Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Implantica AG's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Implantica AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (STU:8IM1) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

IMP A SDB:Sweden

Address

Aeulestrasse 45, Vaduz, LIE, 9490

Website

https://www.implantica.com

Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. To bring advanced technology into the body, and adequate energy supply is required which would require very large batteries, so, Implantica has developed a wireless energising platform to supply energy to the body through intact skin.

Implantica AG Headlines

No Headlines